AL
KYNB

Airain Ltd’s Kyntra Bio KYNB Stock Holding History

Airain Ltd’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$484K Buy
599
+217
+57% +$151K 0.02% 550
2017
Q1 		$236K Buy
+382
New +$233K 0.01% 690
2016
Q1 		– Sell
-657
Closed -$500K – 875
2015
Q4 		$500K Sell
657
-905
-58% -$601K 0.03% 464
2015
Q3 		$856K Buy
+1,562
New +$946K 0.05% 364

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Airain Ltd's KYNB Position: Q2 2017 in Review

Airain Ltd increased its Kyntra Bio (KYNB) stake by 57% in Q2 2017, buying an estimated $151K and bringing the position to 599 shares worth $484K. The position accounts for 0.02% of the portfolio, ranked #550.

Airain Ltd first reported a position in KYNB in Q3 2015 and has held it in 4 quarters since. The position peaked at $856K in Q3 2015. 151 funds tracked by Wall St. Rank hold KYNB as of Q2 2017.

  • Airain Ltd held 599 shares of Kyntra Bio worth $484K as of Q2 2017.
  • Airain Ltd bought 217 Kyntra Bio shares in Q2 2017, an estimated $151K.
  • Kyntra Bio made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #550 holding.
  • Airain Ltd first reported a position in Kyntra Bio in Q3 2015 and has held it in 4 quarters since.
  • Airain Ltd's Kyntra Bio position peaked at $856K in Q3 2015.
  • 151 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.